Updated Prostate Cancer Screening Guidelines Announced
Shared decision-making about screening recommended for men aged 55-69 years.
AUA 2013: Prostate Cancer
Prostate Cancer Deaths Occurring at Older Ages
Median survival time from diagnosis improved by a median of 43 months from the pre-PSA to the post-PSA era.
Prostate Cancer Risk Not Elevated with Testosterone Replacement
In fact, men on testosterone replacement therapy (TRT) had a lower PCa rate than men not on TRT.
Sildenafil Preserves Erectile Function in Radiotherapy Patients
Data support prophylactic use of a PDE-5 inhibitor in men receiving radiotherapy for prostate cancer.
Intermittent Prostate Cancer Chemo Beneficial
This approach can reduce adverse events without impairing efficacy.
Post-RARP Weight Gain May Worsen Urinary Incontinence
Study finds a significant inverse association between weight changes and incontinence scores in normal-weight patients.
SVI, LNI Have Similar Effect on Prostate Cancer Survival
New findings underscore the importance of achieve maximal tumor control in patients with high-risk disease.
Data Support RP for Localized Advanced Prostate Cancer
Patients with pT4 tumors had five-year cancer-specific and overall survival rates of 91%.
Prostate Cancer Active Surveillance Reasonable, Long-Term Data Show
After more than 10 years of follow-up, 54% of patients progressed, but only one patient died from prostate cancer.
Prostate Cancer Radiotherapy Hikes Risk of Second Cancers
Study reveals an elevated risk of lung cancer, which researchers called an intriguing finding.
- Loading...
Loading...
Want to read more?
Please login or register first to view this content.
Loading... 
Loading...